Company / Depreciation & Amortization
West Pharmaceutical Services Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$171.4M
FY2025
5-year range
$103.4M / $171.4M
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#48 of 142
Health Care
What the data says
At $171M, West Pharmaceutical Services's depreciation & amortization ranks #95 of 142 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $103M in FY2021 to $171M in FY2025.
Based on SEC 10-K filings.
$171M in FY2025 with a 5-year CAGR of +10.4%.
Increased from $137M to $171M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +16.3%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
#95 of 142 in Health CareTop 66% of 142This company $171.4M Sector average $347.4M
▼
-50.7% below sector average
Key checks
Key Insights
- West Pharmaceutical Services's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +10.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 10.3% year-over-year.
- Ranks #48 out of 142 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $171.4M | +10.3% |
| FY2024 | $155.4M | +13.2% |
| FY2023 | $137.3M | +25.8% |
| FY2022 | $109.1M | +5.5% |
| FY2021 | $103.4M | -1.0% |
| FY2020 | $104.4M | +1.0% |
| FY2019 | $103.4M | -1.0% |
| FY2018 | $104.4M | +8.0% |
| FY2017 | $96.7M | +7.4% |
| FY2016 | $90.0M | +5.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026